Performance of Galactomannan, Beta-d-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for …
Galactomannan detection in bronchoalveolar lavage (BAL) fluid samples (GM test) is
currently considered the gold standard test for diagnosing invasive pulmonary aspergillosis …
currently considered the gold standard test for diagnosing invasive pulmonary aspergillosis …
Point of care testing for the diagnosis of fungal infections: are we there yet?
Diagnostic tools for invasive fungal infections have continuously improved within the last
decades. Nowadays, cultural methods, antigen testing, and molecular tests, such as …
decades. Nowadays, cultural methods, antigen testing, and molecular tests, such as …
Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases
J Prattes, H Flick, F Prüller, C Koidl… - American journal of …, 2014 - atsjournals.org
Rationale: Invasive pulmonary aspergillosis has been increasingly reported in
nonneutropenic patients, including those with underlying respiratory diseases. Objectives …
nonneutropenic patients, including those with underlying respiratory diseases. Objectives …
[HTML][HTML] Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter …
Y Sun, F Meng, M Han, X Zhang, L Yu, H Huang… - Biology of Blood and …, 2015 - Elsevier
Abstract The China Assessment of Antifungal Therapy in Hematological Disease study, the
first large-scale observational study of invasive fungal disease (IFD) in China, enrolled 1401 …
first large-scale observational study of invasive fungal disease (IFD) in China, enrolled 1401 …
A systematic review to assess the relationship between disseminated cerebral aspergillosis, leukemias and lymphomas, and their respective therapeutics
BN Sullivan, MA Baggett, SS O'Connell, KM Pickett… - Journal of Fungi, 2022 - mdpi.com
Disseminated disease following invasive pulmonary aspergillosis (IPA) remains a significant
contributor to mortality amongst patients with hematologic malignancies (HMs). At the …
contributor to mortality amongst patients with hematologic malignancies (HMs). At the …
Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test
The effect of mould-active antifungal (AF) therapy/prophylaxis on the performance of the
Aspergillus-specific lateral-flow device (LFD) test for diagnosing invasive pulmonary …
Aspergillus-specific lateral-flow device (LFD) test for diagnosing invasive pulmonary …
Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China
Y Sun, H Huang, J Chen, J Li, J Ma, J Li, Y Liang… - Tumor Biology, 2015 - Springer
This stud y examined the epidemiology, risk factors, management, and outcome of invasive
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …
Epidemiology of invasive fungal diseases in patients with hematologic malignancies and hematopoietic cell transplantation recipients managed with an antifungal …
MD Bergamasco, CAP Pereira, C Arrais-Rodrigues… - Journal of Fungi, 2021 - mdpi.com
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …
European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with …
M Hoenigl, V Strenger, W Buzina… - Journal of …, 2012 - academic.oup.com
Objectives Fulfilment of host factors defined by the revised European Organization for the
Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria is required …
Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria is required …
Diagnostic accuracy of the Aspergillus‐specific bronchoalveolar lavage lateral‐flow assay in haematological malignancy patients
We evaluated the performance of the Aspergillus‐specific lateral‐flow device (LFD) test for
diagnosing invasive pulmonary aspergillosis (IPA) in patients with underlying …
diagnosing invasive pulmonary aspergillosis (IPA) in patients with underlying …